![Cancers | Free Full-Text | Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine Cancers | Free Full-Text | Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine](https://www.mdpi.com/cancers/cancers-14-03876/article_deploy/html/images/cancers-14-03876-g001.png)
Cancers | Free Full-Text | Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine
![Comparison of outcomes between neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy in patients with locally advanced esophageal cancer: A network meta-analysis - eClinicalMedicine Comparison of outcomes between neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy in patients with locally advanced esophageal cancer: A network meta-analysis - eClinicalMedicine](https://www.thelancet.com/cms/asset/32e9db11-f570-4d13-b53a-f0f642d88d11/gr1.jpg)
Comparison of outcomes between neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy in patients with locally advanced esophageal cancer: A network meta-analysis - eClinicalMedicine
![Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology](https://www.thelancet.com/cms/attachment/34b2410d-db54-46e1-ac1d-1d1894292938/gr1_lrg.gif)
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology
![Short-term outcome of neoadjuvant immunotherapy and chemotherapy in non–small cell lung cancer: A systematic review and meta-analysis - ScienceDirect Short-term outcome of neoadjuvant immunotherapy and chemotherapy in non–small cell lung cancer: A systematic review and meta-analysis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666273621002680-fx1.jpg)
Short-term outcome of neoadjuvant immunotherapy and chemotherapy in non–small cell lung cancer: A systematic review and meta-analysis - ScienceDirect
![Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma - European Urology Focus Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/attachment/5f6974d7-152f-4d2c-976e-e3d3e3f1f649/gr1.jpg)
Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma - European Urology Focus
![Discrepancy of Breast and Axillary Pathologic Complete Response and Outcomes in Different Subtypes of Node-positive Breast Cancer after Neoadjuvant Chemotherapy Discrepancy of Breast and Axillary Pathologic Complete Response and Outcomes in Different Subtypes of Node-positive Breast Cancer after Neoadjuvant Chemotherapy](https://www.jcancer.org/v12/p5365/toc.jpg)
Discrepancy of Breast and Axillary Pathologic Complete Response and Outcomes in Different Subtypes of Node-positive Breast Cancer after Neoadjuvant Chemotherapy
![Neoadjuvant chemotherapy increases rates of breast-conserving surgery in early operable breast cancer | HKMJ Neoadjuvant chemotherapy increases rates of breast-conserving surgery in early operable breast cancer | HKMJ](https://www.hkmj.org/system/files/hkmj164972-table4.jpg)
Neoadjuvant chemotherapy increases rates of breast-conserving surgery in early operable breast cancer | HKMJ
![Survival Outcomes for Patients With Clinical Complete Response After Neoadjuvant Chemotherapy: Is Omitting Surgery an Option? | Annals of Surgical Oncology Survival Outcomes for Patients With Clinical Complete Response After Neoadjuvant Chemotherapy: Is Omitting Surgery an Option? | Annals of Surgical Oncology](https://media.springernature.com/m685/springer-static/image/art%3A10.1245%2Fs10434-019-07534-1/MediaObjects/10434_2019_7534_Fig1_HTML.png)
Survival Outcomes for Patients With Clinical Complete Response After Neoadjuvant Chemotherapy: Is Omitting Surgery an Option? | Annals of Surgical Oncology
![Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27 | Journal of Clinical Oncology Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27 | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2012/jco.2012.43.30.issue-32/jco.2012.43.30.issue-32/20160922/jco.2012.43.30.issue-32.largecover.png)
Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27 | Journal of Clinical Oncology
![Survival outcomes for dose‐dense paclitaxel plus carboplatin neoadjuvant vs standard adjuvant chemotherapy in stage II to III triple‐negative breast cancer: A prospective cohort study with propensity‐matched analysis - Xiu - 2022 - Survival outcomes for dose‐dense paclitaxel plus carboplatin neoadjuvant vs standard adjuvant chemotherapy in stage II to III triple‐negative breast cancer: A prospective cohort study with propensity‐matched analysis - Xiu - 2022 -](https://onlinelibrary.wiley.com/cms/asset/57bcd5d6-acc1-43b5-a184-333567c07174/ijc34022-toc-0001-m.jpg?trick=1703151505868)
Survival outcomes for dose‐dense paclitaxel plus carboplatin neoadjuvant vs standard adjuvant chemotherapy in stage II to III triple‐negative breast cancer: A prospective cohort study with propensity‐matched analysis - Xiu - 2022 -
![PDF) Oncological outcome of complete response after neoadjuvant chemotherapy for breast conserving surgery: A systematic review and meta-analysis PDF) Oncological outcome of complete response after neoadjuvant chemotherapy for breast conserving surgery: A systematic review and meta-analysis](https://i1.rgstatic.net/publication/321358385_Oncological_outcome_of_complete_response_after_neoadjuvant_chemotherapy_for_breast_conserving_surgery_A_systematic_review_and_meta-analysis/links/5a1f92aa458515a4c3d4aa12/largepreview.png)
PDF) Oncological outcome of complete response after neoadjuvant chemotherapy for breast conserving surgery: A systematic review and meta-analysis
![Cureus | Neoadjuvant Therapy and Factors Influencing Survival in Locally Advanced Non-Small Cell Lung Cancer | Article Cureus | Neoadjuvant Therapy and Factors Influencing Survival in Locally Advanced Non-Small Cell Lung Cancer | Article](https://assets.cureus.com/uploads/figure/file/524304/article_river_83d780a0849711eda2f08902626b9bd0-Figure-1..png)
Cureus | Neoadjuvant Therapy and Factors Influencing Survival in Locally Advanced Non-Small Cell Lung Cancer | Article
![Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint. | Semantic Scholar Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2a5cff93f34ad2baa7b2ce48db639064f71d844d/5-Table3-1.png)
Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint. | Semantic Scholar
![Despite Equivalent Outcomes, Men Receive Neoadjuvant Chemotherapy Less Often Than Women for Lymph Node-Positive Breast Cancer | Annals of Surgical Oncology Despite Equivalent Outcomes, Men Receive Neoadjuvant Chemotherapy Less Often Than Women for Lymph Node-Positive Breast Cancer | Annals of Surgical Oncology](https://media.springernature.com/m685/springer-static/image/art%3A10.1245%2Fs10434-021-09994-w/MediaObjects/10434_2021_9994_Figa_HTML.png)
Despite Equivalent Outcomes, Men Receive Neoadjuvant Chemotherapy Less Often Than Women for Lymph Node-Positive Breast Cancer | Annals of Surgical Oncology
![Frontiers | Prolonged neoadjuvant chemotherapy without radiation versus total neoadjuvant therapy for locally advanced rectal cancer: A propensity score matched study Frontiers | Prolonged neoadjuvant chemotherapy without radiation versus total neoadjuvant therapy for locally advanced rectal cancer: A propensity score matched study](https://www.frontiersin.org/files/Articles/953790/fonc-12-953790-HTML/image_m/fonc-12-953790-g001.jpg)
Frontiers | Prolonged neoadjuvant chemotherapy without radiation versus total neoadjuvant therapy for locally advanced rectal cancer: A propensity score matched study
![Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR) | Breast Cancer Research | Full Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR) | Breast Cancer Research | Full](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13058-018-1091-y/MediaObjects/13058_2018_1091_Fig4_HTML.png)
Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR) | Breast Cancer Research | Full
![Treatment patterns and clinical outcomes of chemotherapy treatment in patients with muscle-invasive or metastatic bladder cancer in the Netherlands | Scientific Reports Treatment patterns and clinical outcomes of chemotherapy treatment in patients with muscle-invasive or metastatic bladder cancer in the Netherlands | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-72820-y/MediaObjects/41598_2020_72820_Fig1_HTML.png)
Treatment patterns and clinical outcomes of chemotherapy treatment in patients with muscle-invasive or metastatic bladder cancer in the Netherlands | Scientific Reports
![Frontiers | The outcome of neoadjuvant chemotherapy and the current trend of surgical treatment in young women with breast cancer: A multicenter real-world study (CSBrS-012) Frontiers | The outcome of neoadjuvant chemotherapy and the current trend of surgical treatment in young women with breast cancer: A multicenter real-world study (CSBrS-012)](https://www.frontiersin.org/files/Articles/1100421/fpubh-11-1100421-HTML/image_m/fpubh-11-1100421-g002.jpg)